IRIS PubliCatt

Montuschi, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.641
EU - Europa 2.354
AS - Asia 693
OC - Oceania 13
SA - Sud America 11
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.723
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.624
SE - Svezia 545
DE - Germania 519
CN - Cina 387
IT - Italia 334
UA - Ucraina 262
IE - Irlanda 172
SG - Singapore 135
PL - Polonia 98
GB - Regno Unito 93
FR - Francia 84
FI - Finlandia 68
RU - Federazione Russa 59
TR - Turchia 57
IN - India 45
BE - Belgio 32
NL - Olanda 22
CA - Canada 15
AT - Austria 14
HK - Hong Kong 14
IR - Iran 13
AU - Australia 11
ES - Italia 11
JP - Giappone 11
CH - Svizzera 9
KR - Corea 7
BG - Bulgaria 6
BR - Brasile 5
CZ - Repubblica Ceca 5
IL - Israele 5
EU - Europa 4
PK - Pakistan 4
RS - Serbia 4
VN - Vietnam 4
ZA - Sudafrica 4
CL - Cile 3
ID - Indonesia 3
LU - Lussemburgo 3
PT - Portogallo 3
AR - Argentina 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
IM - Isola di Man 2
IS - Islanda 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TW - Taiwan 2
YE - Yemen 2
BZ - Belize 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
KZ - Kazakistan 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
Totale 5.723
Salva come PNG Salva come JPEG
Città #
Chandler 482
Ashburn 264
Dublin 168
San Mateo 147
Jacksonville 120
Cattolica 114
Nanjing 109
Ann Arbor 100
Warsaw 98
Bremen 87
Singapore 83
Wilmington 83
Woodbridge 73
Boston 69
New York 69
Fairfield 59
Lawrence 55
Redwood City 54
Moscow 50
Izmir 46
Dearborn 43
Munich 39
Seattle 39
Houston 37
Milan 35
Beijing 32
Princeton 32
Rome 32
Brussels 29
Boardman 26
Hangzhou 26
Nanchang 21
Shanghai 21
Guangzhou 20
Los Angeles 20
Nürnberg 20
Marseille 19
Cambridge 18
Mountain View 18
Norwalk 18
Columbus 17
Redmond 17
Shenyang 15
Fremont 14
Hebei 14
Chicago 13
Tianjin 12
Falls Church 11
Jiaxing 11
Vienna 11
Changsha 10
University Park 10
Detroit 9
Lancaster 9
Pune 9
Zhengzhou 9
Changchun 8
Amsterdam 7
Edinburgh 7
Kunming 7
London 7
Augusta 6
Bergamo 6
Kish 6
Leawood 6
Montreal 6
Philadelphia 6
Southend 6
Washington 6
Ypsilanti 6
Buffalo 5
Busto Arsizio 5
Istanbul 5
Latina 5
Sacramento 5
Brno 4
Helsinki 4
Indiana 4
Jinan 4
Lappeenranta 4
Napoli 4
Paris 4
Simi Valley 4
Tappahannock 4
Andover 3
Bern 3
Bromley 3
Central 3
Esslingen am Neckar 3
Frankfurt am Main 3
Goodyear 3
Hefei 3
Hounslow 3
Karachi 3
Luxembourg 3
Modderfontein 3
Mumbai 3
Nuremberg 3
Pusan 3
Reggio Calabria 3
Totale 3.265
Salva come PNG Salva come JPEG
Nome #
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 247
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 159
Development of a sensing array for human breath analysis based on SWCNT layers functionalized with semiconductor organic molecules 140
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 124
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 123
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 120
Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients 120
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 118
Computed tomography for evaluation of the small airway disease in asthma. 118
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD 105
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 104
Inhaled muscarinic acethylcholine receptor antagonists for treatment of COPD 103
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 102
Dupilumab for the treatment of asthma 96
Investigational prostaglandin D2 receptor antagonists for airway inflammation 95
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 94
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics 92
Impact of air pollution on respiratory diseases in urban areas: a systematic review 89
Exhaled Nitric Oxide Measurement in Patients Affected by Nasal Polyposis 88
Development of a Sensing Array for Human Breath Analysis Based on SWCNT Layers Functionalized with Semiconductor Organic Molecules 87
NMR spectroscopy-based metabolomics of exhaled breath condensate in inflammatory respiratory diseases 84
Indirect monitoring of lung inflammation 82
Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children 76
Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases 73
Pharmacotherapy of asthma: regular treatment or on demand? 73
Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends 73
8-isoprostane in exhaled breath condensate after experimental exposure to wood smoke in humans 72
Exploring the performance of a functionalized CNT-based sensor array for breathomics through clustering and classification algorithms: From gas sensing of selective biomarkers to discrimination of chronic obstructive pulmonary disease 69
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 68
Comparison of classification methods in breath analysis by electronic nose 68
NMR-Based Metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease Patients 67
Role of beta-blockers in patients with COPD: current perspective 66
Stratification of asthma phenotypes by airway proteomic signatures 66
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort 65
Dupilumab for the treatment of asthma 65
The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study 63
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 63
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 62
WHITIN-DAY AND BETWEEN-DAY REPEATIBILITY OF MEASURERMENTS WITH AN ELECTRONIC NOSE IN PATIENTS WITH COPD 61
Impulse oscillometry and nitrogen washout test in the assessment of small airway dysfunction in asthma: correlation with quantitative computed tomography 60
LC/MS/MS analysis of leukotriene B4 in exhaled breath condensate for assessing lung inflammation. 58
8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. 58
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues 57
Severe asthma: One disease and multiple definitions 57
Triple inhaled therapy for chronic obstructive pulmonary disease 56
Drugs for chronic obstructive pulmonary disease. 55
Leukotriene modifiers for asthma treatment 54
The electronic nose in respiratory medicine. 54
Immediate allergic reactions to beta-lactams: diagnosis and therapy. 52
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD 52
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 50
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 50
Exhaled breath condensate in COPD: application in clinical practice 49
Separating Smoking-Related Diseases Using NMR-Based Metabolomics of Exhaled Breath Condensate 49
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 49
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects 48
Comparison of two exhaled biomarkers in children with and without sleep disordered breathing 47
Exhaled nitric oxide as a biomarker in COPD and related comorbidities 46
Treatable traits in the European U-BIOPRED adult asthma cohorts 46
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 45
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 45
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma 45
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. 44
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping 44
Predictive markers of bronchial hyperreactivity in a large cohort of young adults With cough variant asthma 44
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. 43
Exhaled breath condensate, nasal eosinophil cationic protein level and nasal cytology during immunotherapy for cypress allergy. 43
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma 43
New perspectives in pharmacological treatment of mild persistent asthma 40
Non-invasive biomarkers of lung inflammation in smoking subjects 40
Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects 40
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis 40
High sputum total adiponectin is associated with low odds for asthma. 39
IL-17-high asthma with features of a psoriasis immunophenotype 39
Vilanterol trifenatate for the treatment of COPD 38
Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project 38
Exhaled breath condensate biomarkers of airway inflammation and oxidative stress in COPD 35
Exhaled volatile organic compounds as markers for medication use in asthma 34
Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis 33
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux 33
Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis. 32
Role of beta-blockers in patients with COPD: current perspective 31
Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids 29
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers 25
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 25
Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study 23
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis 19
Editorial: Insights in respiratory pharmacology: 2021 19
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy 17
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 17
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study 16
A European Respiratory Society technical standard: exhaled biomarkers in lung disease 16
Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort 15
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort 15
Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome 13
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease 12
Totale 5.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020458 0 0 28 31 37 54 45 17 24 16 112 94
2020/2021668 31 81 21 73 80 24 57 16 102 49 117 17
2021/2022861 56 64 22 67 65 35 21 138 37 46 173 137
2022/20231.617 200 212 130 273 131 224 48 124 184 17 45 29
2023/2024808 34 245 17 113 25 104 56 10 7 38 63 96
2024/202584 32 50 2 0 0 0 0 0 0 0 0 0
Totale 5.856